MECTA Electroshock Device Manufacturer Files for Bankruptcy as its Shock Box Loses Liability Insurance

Company dismisses ECT dangers and, instead, blames ECT critics and lawsuits for its financial demise; CCHR accuses MECTA of ignoring damaging adverse effects of shock treatment.

March 28, 2022 by CCHR International

MECTA Corp., one of the USA’s two manufacturers of electroshock machines, filed for bankruptcy (9/30/2021) following lawsuits related to the company’s SpECTrum device. MECTA (Monitored Electro-Convulsive Therapy Apparatus) cited lawsuits, filed by patients seeking redress over electroshock-caused brain damage and serious memory loss, as the reason for its bankruptcy. The company was thus unable to obtain product liability insurance to cover the device.

CCHR International’s website TruthAboutECT.org also provides expert statements and quotes, including successful ECT lawsuits and death findings that consumers, in the interest of informed consent and compensation for damage, should be aware of.

The other ECT device manufacturer, Somatics LLC, posted a notice admitting that patients subjected to their Thymatron┬« ECT device “may experience permanent memory loss or permanent brain damage.”

Neither MECTA nor Somatics have conducted clinical trials to prove the safety and efficacy of their devices.

Even the U.S. Food and Drug Administration (FDA) states that “Long-term safety and effectiveness of ECT treatment has not been demonstrated.”

Watch the CCHR documentary, Therapy or Torture: The Truth About Electroshock, which includes interviews with more than a dozen experts, including a psychiatrist, psychologists, physicians, nurses, and attorneys, as well as shock treatment survivors. The documentary provides facts demonstrating the harm done by ECT.

Tags:

Comments are closed.